NASDAQ · Financial Statements

Lumexa Imaging Holdings, Inc. (LMRI) Financial Statements

$10.54 NASDAQ: LMRI Market Cap $1.01B

Lumexa Imaging Holdings, Inc. most recently reported annual revenue of $1.0B, net profit of $-47.0M, revenue has compounded at 4.5% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric202320242025
Revenue$936.0M$949.0M$1.0B
Operating Profit$22.0M$55.0M$27.0M
Net Profit$-122.0M$-94.0M$-47.0M
EPS$-1.29$-1.00$-0.66
Op Margin2.4%5.8%2.6%

Balance Sheet (USD)

Metric202320242025
Total Assets$1.7B$1.7B$1.8B
Total Liabilities$1.5B$1.5B$1.2B
Cash$20.0M$26.0M$59.0M
Borrowings$1.3B$1.3B$963.0M

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$38.0M$41.0M$17.0M
Investing Cash Flow$-54.0M$-50.0M$-44.0M
Financing Cash Flow$0$-1.0M$2.0M
Net Cash Flow$-1.0M$6.0M$33.0M
Free Cash Flow$14.0M$13.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.19
EV / EBITDA17.92
FCF Yield2.92%
Quick Ratio1.44
Interest Coverage0.16
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
LMRI Overview LMRI Dividend Run Stock Screener